Inventor
ROBIN JEAN-PIERRE
FR22 patents
⚠️ This page may combine multiple inventors who share the name “ROBIN JEAN-PIERRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SERIPHARM
5 patentsUS6265587B1Jul 24, 2001
Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor
SERIPHARM12 citations78
US7279586B2Oct 9, 2007
Intermediates for the hemisynthesis of taxanes and preparation processes therefor
SERIPHARM0 citations48
US7220871B2May 22, 2007
Intermediates for the hemisynthesis of taxanes and preparation processes therefor
SERIPHARM0 citations48
US7432383B2Oct 7, 2008
Intermediates for the hemisynthesis of taxanes and preparation processes therefor
SERIPHARM0 citations46
US6180802B1Jan 30, 2001
Method for selective protection of baccatin derivatives and its application to taxane synthesis
SERIPHARM1 citations46
PF MEDICAMENT
3 patentsUS6107284AAug 22, 2000
Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments
PF MEDICAMENT16 citations82
US5643885AJul 1, 1997
Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment
PF MEDICAMENT4 citations62
US5386016AJan 31, 1995
2",3",4'-tri(acetyl)-4",6"-ethylidine-β-D-glucopyranosides, their preparation and their use for the preparation of 4'-demethylepipodophyliotoxing ethylidene-β-D-glucopyranoside
PF MEDICAMENT1 citations42
STRAGEN PHARMA S A
3 patentsUS7169774B2Jan 30, 2007
Cephalotaxane derivatives and their processes of preparation and purification
STRAGEN PHARMA S A8 citations69
US6987103B2Jan 17, 2006
Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents
STRAGEN PHARMA S A10 citations63
US7285546B2Oct 23, 2007
Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
STRAGEN PHARMA S A4 citations55
SOLARONICS PROCESS SA
2 patentsONCOPHARM CORP
2 patentsUS6613900B2Sep 2, 2003
Cephalotaxane derivatives and process for their preparation
ONCOPHARM CORP11 citations66
US6579869B1Jun 17, 2003
Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents
ONCOPHARM CORP6 citations54